Equities

Nagaileben Co Ltd

Nagaileben Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,260.00
  • Today's Change36.00 / 1.62%
  • Shares traded17.50k
  • 1 Year change+1.80%
  • Beta0.2703
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Nagaileben Co Ltd's revenues fell -4.48% from 17.18bn to 16.41bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 3.23bn to 2.82bn, a -12.53% decrease.
Gross margin42.83%
Net profit margin17.19%
Operating margin24.40%
Return on assets6.00%
Return on equity6.57%
Return on investment6.43%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Nagaileben Co Ltd fell by 2.41bn. However, the company earned 2.29bn from its operations for a Cash Flow Margin of 13.93%. In addition the company used 1.77bn on investing activities and also paid 2.93bn in financing cash flows.
Cash flow per share75.30
Price/Cash flow per share33.20
Book value per share1,355.91
Tangible book value per share1,353.61
More ▼

Balance sheet in JPYView more

Nagaileben Co Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio12.32
Quick ratio10.20
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in JPY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -11.27%. Additionally when measured on a five year annualized basis, dividend per share growth is below the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)2.53%
Div growth rate (5 year)0.00%
Payout ratio (TTM)0.00%
EPS growth(5 years)-3.05
EPS (TTM) vs
TTM 1 year ago
-11.23
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.